+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Cardiopulmonary Bypass Equipment Market Report and Forecast 2024-2032

  • PDF Icon

    Report

  • 160 Pages
  • September 2023
  • Region: Global
  • Expert Market Research
  • ID: 5895175
The global cardiopulmonary bypass equipment market size was valued at USD 464.3 million in 2023, driven by the increasing technological advancements in cardiac surgery techniques across the globe. The market size is anticipated to grow at a CAGR of 7.4% during the forecast period of 2024-2032 to achieve a value of USD 883.9 million by 2032.

Cardiopulmonary Bypass Equipment: Introduction

Cardiopulmonary bypass (CPB) equipment, often referred to as heart-lung machines or perfusion systems, is a specialized medical device used during cardiac surgery to temporarily take over the functions of the heart and lungs. It allows surgeons to perform complex cardiac procedures by diverting the patient's blood away from the heart and lungs, oxygenating and filtering it, and then returning it to the patient's body. This temporary support system maintains the patient's circulation and oxygenation while the surgeon operates on the heart or other related structures.

Key Trends in the Global Cardiopulmonary Bypass Equipment Market

Here are some trends that were affecting the cardiopulmonary bypass equipment market:

  • Technological Advancements: Continuous advancements in technology were driving innovation in cardiopulmonary bypass equipment. These innovations included improvements in the design of heart-lung machines, oxygenators, and monitoring systems. Advancements aimed to enhance safety, reduce the risk of complications, and improve patient outcomes during cardiac surgeries.
  • Minimally Invasive Procedures: There was a growing trend toward minimally invasive cardiac surgeries, such as minimally invasive coronary artery bypass grafting (CABG) and transcatheter aortic valve replacement (TAVR). These procedures often require specialized equipment, and manufacturers were developing bypass equipment tailored for minimally invasive techniques.
  • Patient-Centric Care: The focus on patient outcomes and satisfaction continued to influence the market. Equipment designed to reduce trauma, complications, and recovery times for patients undergoing cardiac surgeries was in demand. Patient-centric care also encouraged the development of less invasive approach.
  • Integrated Systems: The integration of various components within cardiopulmonary bypass systems was a trend. This allowed for better control and monitoring of parameters during surgery, streamlined workflow, and reduced the risk of errors.
  • Remote Monitoring and Telemedicine: The COVID-19 pandemic accelerated the adoption of remote monitoring and telemedicine in healthcare. Manufacturers were exploring ways to incorporate remote monitoring and data-sharing capabilities into cardiopulmonary bypass equipment to facilitate real-time collaboration among healthcare professionals.
  • Focus on Safety: Safety was a paramount concern in cardiac surgery. Equipment designed with safety features, such as alarms and fail-safes, helped reduce the risk of complications during cardiopulmonary bypass procedures.

Global Cardiopulmonary Bypass Equipment Market Segmentations

The market can be categorized into type, end user, and region.

Market Breakup by Type

  • Single Roller Pump
  • Double Roller Pump

Market Breakup by End User

  • Hospitals
  • Ambulatory Surgical Centres

Market Breakup by Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Global Cardiopulmonary Bypass Equipment Market Overview

Here are some key drivers for the cardiopulmonary bypass equipment market:

  • Growing Prevalence of Cardiovascular Diseases: The rising incidence of cardiovascular diseases, including coronary artery disease and valvular heart disease, is a major driver for the cardiopulmonary bypass equipment market. As the population ages and lifestyles contribute to heart-related conditions, the demand for cardiac surgeries increases.
  • Advancements in Cardiac Surgery: Technological advancements in cardiac surgery techniques, such as minimally invasive procedures and robotic-assisted surgeries, are driving the demand for advanced CPB equipment that can support these surgical approaches.
  • Increasing Aging Population: The aging global population is more susceptible to heart diseases, necessitating more cardiac surgeries. The elderly often require complex cardiac procedures that may involve CPB equipment.
  • Rise in Complex Heart Procedures: Surgeons are increasingly performing complex cardiac procedures, including multi-valve surgeries, combined coronary artery bypass grafting (CABG) and valve procedures, and congenital heart defect repairs. These procedures often require advanced CPB technology.
  • Global Expansion of Healthcare Infrastructure: Emerging markets, especially in Asia and Latin America, are witnessing an expansion of healthcare infrastructure. This includes the development of cardiac care centres and hospitals with advanced surgical capabilities, contributing to the growth of the CPB equipment market.
  • Technological Innovations: Ongoing technological advancements in CPB equipment, such as the development of safer and more efficient heart-lung machines, oxygenators, and monitoring systems, drive the market by enhancing patient outcomes and surgical efficiency.

Global Cardiopulmonary Bypass Equipment Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players.

The major companies in the market are as follows:

  • Medtronic
  • LivaNova Plc
  • MAQUET Holding
  • Abiomed
  • Brail Biomedica
  • Tianjin Medica
  • Terumo Corp
  • Senko Medical Instrument Manufacturing Co.
  • Technowood Corp
  • Sorin
The publisher always strives to provide you with the latest information. The numbers in the article are only indicative and may be different from the actual report.

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Cardiopulmonary Bypass Equipment Market Overview
3.1 Global Cardiopulmonary Bypass Equipment Market Historical Value (2017-2023)
3.2 Global Cardiopulmonary Bypass Equipment Market Forecast Value (2024-2032)
4 Global Cardiopulmonary Bypass Equipment Market Landscape
4.1 Global Cardiopulmonary Bypass Equipment: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Cardiopulmonary Bypass Equipment: Product Landscape
4.2.1 Analysis by Method
4.2.2 Analysis by Technology
4.2.3 Analysis by Applications
5 Global Cardiopulmonary Bypass Equipment Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Cardiopulmonary Bypass Equipment Market Segmentation
6.1 Global Cardiopulmonary Bypass Equipment Market by Type
6.1.1 Market Overview
6.1.2 Single Roller Pump
6.1.3 Double Roller Pump
6.2 Global Cardiopulmonary Bypass Equipment Market by End User
6.2.1 Market Overview
6.2.2 Hospitals
6.2.3 Ambulatory Surgical Centres
6.3 Global Cardiopulmonary Bypass Equipment Market by Region
6.3.1 Market Overview
6.3.2 North America
6.3.3 Europe
6.3.4 Asia Pacific
6.3.5 Latin America
6.3.6 Middle East and Africa
7 North America Cardiopulmonary Bypass Equipment Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Cardiopulmonary Bypass Equipment Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Cardiopulmonary Bypass Equipment Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Cardiopulmonary Bypass Equipment Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Cardiopulmonary Bypass Equipment Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Regulatory Framework
12.1 Regulatory Overview
12.1.1 US FDA
12.1.2 EU EMA
12.1.3 INDIA CDSCO
12.1.4 JAPAN PMDA
12.1.5 Others
13 Patent Analysis
13.1 Analysis by Type of Patent
13.2 Analysis by Publication year
13.3 Analysis by Issuing Authority
13.4 Analysis by Patent Age
13.5 Analysis by CPC Analysis
13.6 Analysis by Patent Valuation
13.7 Analysis by Key Players
14 Grants Analysis
14.1 Analysis by year
14.2 Analysis by Amount Awarded
14.3 Analysis by Issuing Authority
14.4 Analysis by Grant Application
14.5 Analysis by Funding Institute
14.6 Analysis by NIH Departments
14.7 Analysis by Recipient Organization
15 Clinical Trials Analysis
15.1 Analysis by Trial Registration Year
15.2 Analysis by Trial Status
15.3 Analysis by Trial Phase
15.4 Analysis by Therapeutic Area
15.5 Analysis by Geography
16 Funding and Investment Analysis
16.1 Analysis by Funding Instances
16.2 Analysis by Type of Funding
16.3 Analysis by Funding Amount
16.4 Analysis by Leading Players
16.5 Analysis by Leading Investors
16.6 Analysis by Geography
17 Partnership and Collaborations Analysis
17.1 Analysis by Partnership Instances
17.2 Analysis by Type of Partnership
17.3 Analysis by Leading Players
17.4 Analysis by Geography
18 Supplier Landscape
18.1 Medtronic
18.1.1 Financial Analysis
18.1.2 Product Portfolio
18.1.3 Demographic Reach and Achievements
18.1.4 Mergers and Acquisitions
18.1.5 Certifications
18.2 LivaNova Plc
18.2.1 Financial Analysis
18.2.2 Product Portfolio
18.2.3 Demographic Reach and Achievements
18.2.4 Mergers and Acquisitions
18.2.5 Certifications
18.3 MAQUET Holding
18.3.1 Financial Analysis
18.3.2 Product Portfolio
18.3.3 Demographic Reach and Achievements
18.3.4 Mergers and Acquisitions
18.3.5 Certifications
18.4 Abiomed
18.4.1 Financial Analysis
18.4.2 Product Portfolio
18.4.3 Demographic Reach and Achievements
18.4.4 Mergers and Acquisitions
18.4.5 Certifications
18.5 Brail Biomedica
18.5.1 Financial Analysis
18.5.2 Product Portfolio
18.5.3 Demographic Reach and Achievements
18.5.4 Mergers and Acquisitions
18.5.5 Certifications
18.6 Tianjin Medica
18.6.1 Financial Analysis
18.6.2 Product Portfolio
18.6.3 Demographic Reach and Achievements
18.6.4 Mergers and Acquisitions
18.6.5 Certifications
18.7 Terumo Corp
18.7.1 Financial Analysis
18.7.2 Product Portfolio
18.7.3 Demographic Reach and Achievements
18.7.4 Mergers and Acquisitions
18.7.5 Certifications
18.8 Senko Medical Instrument Manufacturing Co.
18.8.1 Financial Analysis
18.8.2 Product Portfolio
18.8.3 Demographic Reach and Achievements
18.8.4 Mergers and Acquisitions
18.8.5 Certifications
18.9 Technowood Corp
18.9.1 Financial Analysis
18.9.2 Product Portfolio
18.9.3 Demographic Reach and Achievements
18.9.4 Mergers and Acquisitions
18.9.5 Certifications
18.10 Sorin
18.10.1 Financial Analysis
18.10.2 Product Portfolio
18.10.3 Demographic Reach and Achievements
18.10.4 Mergers and Acquisitions
18.10.5 Certifications
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket

Companies Mentioned

  • Medtronic
  • LivaNova Plc
  • MAQUET Holding
  • Abiomed
  • Brail Biomedica
  • Tianjin Medica
  • Terumo Corp
  • Senko Medical Instrument Manufacturing Co.
  • Technowood Corp
  • Sorin

Methodology

Loading
LOADING...